Title of article
A rare cause of recurrent modified Blalock-Taussig shunt thrombosis: Antiphospholipid antibodies
Author/Authors
Kıplapınar, Neslihan Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey , Erek, Ersin Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiovascular Surgery, Turkey , Ödemiş, Ender Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey , Öztürk, Erkut Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey
From page
480
To page
481
Abstract
The modified Blalock-Taussig (mBT) shunt is a palliative surgical treatment that increase pulmonary blood flow in patients with cyanotic congenital heart diseases. The incidence of mBT shunt thrombosis is reported to be among 1-17% (1). Several risk factors were defined about shunt thrombosis such as small age, low body weight, hypoplastic pulmonary arteries, small graft size and thrombophilia (1). We present a case of recurrent mBT shunt thrombosis associated with elevations in anticardiolipin antibody levels.
Journal title
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Journal title
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Record number
2692814
Link To Document